ArticleFrontiers in pharmacology2021

A New Chalcone Derivative C49 Reverses Doxorubicin Resistance in MCF-7/DOX Cells by Inhibiting P-Glycoprotein Expression.

Ting Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.